ES2196207T3 - Antagonista heterociclicos de bradicinina sustituidos con fluoroalquilo y fluoroalcoxi. - Google Patents

Antagonista heterociclicos de bradicinina sustituidos con fluoroalquilo y fluoroalcoxi.

Info

Publication number
ES2196207T3
ES2196207T3 ES97103611T ES97103611T ES2196207T3 ES 2196207 T3 ES2196207 T3 ES 2196207T3 ES 97103611 T ES97103611 T ES 97103611T ES 97103611 T ES97103611 T ES 97103611T ES 2196207 T3 ES2196207 T3 ES 2196207T3
Authority
ES
Spain
Prior art keywords
sup
rent
sub
replaced
fluoroalquilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97103611T
Other languages
English (en)
Inventor
Adalbert Dr Wagner
Holger Dr Heitsch
Gerhard Dr Nolkne
Klaus Dr Wirth
Prof-Dr Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2196207T3 publication Critical patent/ES2196207T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D257/12Six-membered rings having four nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE DESCRIBEN FLUORALQUIDERIVADOS Y FLUORALCOXIDERIVADOS HETEROCICLICOS CON LA FORMULA (I) CON EFECTO ANTAGONISTA DE LA BRADIQUININA, DONDE X{SUB,1}-X{SUB,3}N O CR{SUP,5}, R{SUP,1} Y R{SUP,2} SIGNIFICAN H O HALOGENO, R{SUP,3} Y R{SUP,4} H, HALOGENO, ALQUILO O ALQUENILO, R{SUP,5} H, HALOGENO, ALQUILO (SUSTITUIDO), OR{SUP,6}, S-R{SUP,6}, NHR{SUP,6}, ARILO (SUSTITUIDO), ARILALQUILO (SUSTITUIDO), - C(O) - OR{SUP,6} O - C(O) - H, R{SUP,6} Y R{SUP,8} H, ALQUILO, ALQUENILO O ARIL - ALQUILO, R{SUP,7} ALQUILO (SUSTITUIDO) O ALCOXI (SUSTITUIDO), B UN GRUPO AMINOCARBOXILICO, D ALQUENDIILO, ALCANDIILO O (CH{SUB,2}){SUB,N} - Y{SUB,P} - (CH{SUB,2}){SUB,M} -, E OXIGENO O AZUFRE, Y OXIGENO, AZUFRE O NR{SUP,8}, N Y M UN NUMERO DE 0 A 3, O UN NUMERO DE 1 A 3 Y P 0 O 1, ASI COMO SUS SALES FISIOLOGICAMENTE TOLERABLES Y UN METODO PARA SU PREPARACION.
ES97103611T 1996-03-19 1997-03-05 Antagonista heterociclicos de bradicinina sustituidos con fluoroalquilo y fluoroalcoxi. Expired - Lifetime ES2196207T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610784A DE19610784A1 (de) 1996-03-19 1996-03-19 Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2196207T3 true ES2196207T3 (es) 2003-12-16

Family

ID=7788755

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97103611T Expired - Lifetime ES2196207T3 (es) 1996-03-19 1997-03-05 Antagonista heterociclicos de bradicinina sustituidos con fluoroalquilo y fluoroalcoxi.

Country Status (24)

Country Link
US (1) US5859025A (es)
EP (1) EP0796848B1 (es)
JP (1) JP4199315B2 (es)
KR (1) KR970065522A (es)
AR (1) AR006261A1 (es)
AT (1) ATE242215T1 (es)
AU (1) AU1628397A (es)
BR (1) BR9701332A (es)
CA (1) CA2199925A1 (es)
CZ (1) CZ81097A3 (es)
DE (2) DE19610784A1 (es)
DK (1) DK0796848T3 (es)
ES (1) ES2196207T3 (es)
HR (1) HRP970155A2 (es)
HU (1) HUP9700595A1 (es)
ID (1) ID16274A (es)
IL (1) IL120477A0 (es)
NO (1) NO971238L (es)
PL (1) PL318924A1 (es)
PT (1) PT796848E (es)
SI (1) SI0796848T1 (es)
SK (1) SK34897A3 (es)
TR (1) TR199700206A2 (es)
ZA (1) ZA972328B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712960A1 (de) 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
DK1106614T3 (da) * 1999-12-10 2004-04-13 Pfizer 5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
JP2005525398A (ja) * 2002-04-10 2005-08-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ブラジキニン受容体モジュレーターとして有用な新規なヘテロアリールアルキルアミド誘導体
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
US7256207B2 (en) * 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
RU2007131400A (ru) 2005-03-01 2009-04-10 Вайет (Us) Соединения циннолина и их применение в качестве модуляторов х-рецепторов печени
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR085073A1 (es) * 2012-01-11 2013-09-11 Richmond Sa Com Ind Y Financiera Lab Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden
AR113839A1 (es) 2017-11-24 2020-06-17 Pharvaris B V Antagonistas del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
MA61123B1 (fr) 2021-08-05 2024-06-28 Pharvaris Gmbh Composition à base de lipides pour l'administration par voie orale d'antagonistes des récepteurs b2 de la bradykinine
US20250268887A1 (en) 2022-03-25 2025-08-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
ES3062067T3 (en) 2022-03-25 2026-04-08 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996005202A1 (en) * 1994-08-17 1996-02-22 Nippon Hypox Laboratories Inc. Imidazoquinoline derivative
ES2218554T3 (es) * 1994-10-27 2004-11-16 Fujisawa Pharmaceutical Co., Ltd. Piridopirimidonas, quinolinas y n-heterociclos condensados que son antagonistas de bradiquinina.

Also Published As

Publication number Publication date
TR199700206A2 (xx) 1997-10-21
CA2199925A1 (en) 1997-09-19
BR9701332A (pt) 1998-08-18
ID16274A (id) 1997-09-18
KR970065522A (ko) 1997-10-13
JPH107656A (ja) 1998-01-13
PL318924A1 (en) 1997-09-29
EP0796848A1 (de) 1997-09-24
AR006261A1 (es) 1999-08-11
JP4199315B2 (ja) 2008-12-17
NO971238L (no) 1997-09-22
EP0796848B1 (de) 2003-06-04
AU1628397A (en) 1997-09-25
DE59710191D1 (de) 2003-07-10
DK0796848T3 (da) 2003-09-22
US5859025A (en) 1999-01-12
CZ81097A3 (en) 1997-10-15
ATE242215T1 (de) 2003-06-15
PT796848E (pt) 2003-08-29
SK34897A3 (en) 1998-01-14
SI0796848T1 (en) 2003-12-31
HUP9700595A1 (hu) 2000-08-28
MX9702028A (es) 1997-09-30
HU9700595D0 (en) 1997-05-28
DE19610784A1 (de) 1997-09-25
ZA972328B (en) 1997-09-19
HRP970155A2 (en) 1998-04-30
NO971238D0 (no) 1997-03-18
IL120477A0 (en) 1997-07-13

Similar Documents

Publication Publication Date Title
ES2196207T3 (es) Antagonista heterociclicos de bradicinina sustituidos con fluoroalquilo y fluoroalcoxi.
DE69113502D1 (de) Verfahren zur Herstellung von Turbinenschaufeln.
ES2179337T3 (es) Disulfuros de triazolilo.
ATE291890T1 (de) Annulusreparatursystem
DE68904986D1 (de) Verfahren zur herstellung von 1,1,1-trifluor-2,2-dichlorethan.
MX9102585A (es) Metodo para formar mascaras faciales fibrosas de filtracion.
DE69106894D1 (de) Verfahren zur regelung eines generators.
DE3584179D1 (de) Verfahren zur herstellung eines insulinaehnlichen wachstumsfaktors i.
DE3481908D1 (de) Verfahren zur herstellung eines feuerbestaendigen, leichten konstruktionsmaterials.
ES2055424T3 (es) Derivados de n-fenilbenzamida con actividad anti-ulcera y anti-alergia y un metodo para su preparacion.
DK262980A (da) Fremgangsmaade til fremstilling af 2,3-dihydro-2,6,7-trisubstituerede 5-acylbenzofuraner
DE3777015D1 (de) Verfahren zur herstellung einer verschleissbestaendigen schicht.
DE3672818D1 (de) Verfahren zur herstellung von verformbaren, nichtgewobenen stoffbahnen.
DE3785595D1 (de) Verfahren zur herstellung einer verschleissfesten schicht.
DE3574706D1 (de) Chartreusin-derivate, ihre salze, antitumorale zusammensetzungen und verfahren zu ihrer herstellung.
DE3676680D1 (de) Anordnung zur herstellung einer erdreferenz fuer, durch schwebende speisung versorgte besondere teilnehmerschaltungen.
DE68910388D1 (de) Strahlungshärtbare Zusammensetzung zur Herstellung einer abriebbeständigen antistatischen Schicht.
IT8024551A0 (it) Composizioni pigmentate induribili a base di silicati, particolarmente per rivestimenti, intonaci esimili.
AT360028B (de) Verfahren zur herstellung neuer, 5-piperazinyl- substituierter derivate von pyrido-(2.3-b)- -benzothiazepin(1.5) und ihrer salze
ATA259580A (de) Trennvorrichtung, z.b. kuenstliche niere, kopfstueck hiefuer und verfahren zu ihrer herstellung
DE3578879D1 (de) Verfahren zur herstellung von 1,3-dimethyl-2-imidazolidinon.
DE3676953D1 (de) Verfahren zur herstellung faserverstaerkter metallischer verbundwerkstoffe.
ES2178491T3 (es) Composicion para la fabricacion de cuerpos de forma y procedimiento para la preparacion de cuerpos de forma a partir de tal composicion.
ES2128101T3 (es) Metodo y equipo para sostener el crecimiento vegetativo en la cara de un terraplen de fuerte pendiente.
DE3675701D1 (de) Polyoxyalkylen-carbazol-addukt, sowie verfahren zu dessen herstellung.